Claim Ownership

Author:

Subscribed: 0Played: 0
Share

Description

 Episodes
Reverse
Factors like labor, supply costs, and rising costs of capital are making it harder than ever for leaders to develop and implement growth strategies and are showing no signs of letting up anytime soon. In this episode, Rachel (Rae) Woods invites healthcare strategy experts Colin Gelbaugh and Vidal Seegobin to discuss how health systems' growth strategies have shifted and what leaders can do to improve their organizations' trajectories, even if you're only in survival mode right now. Links: 4 health system growth archetypes 'The most difficult year': Why hospital finances are so strained Ep. 142: The dire state of hospital finances (Part 1: Hospital of the Future series) Ep. 143: A new path for a sustainable financial future (Part 2: Hospital of the Future series) Learn how healthcare competition is transforming (www.advisory.com/healthcarecompetition)
In the last Radio Advisory episode host Rachel (Rae) Woods spoke with executive strategy experts Natalie Trebes and Aaron Mauck about the immediate challenges (and opportunities) facing healthcare leaders in 2023. In this episode, Rae continues that conversation with Natalie and Aaron by looking beyond this year to understand where leaders need to focus their attention on longer-term industry challenges – like growing competition, behavioral health infrastructure, and finding success in value-based care. Links: Ep. 145: Part 1: What CEOs need to know in 2023 Ep. 142: The dire state of hospital finances (Part 1: Hospital of the Future series) Ep. 143: A new path for a sustainable financial future (Part 2: Hospital of the Future series) The outlook for healthcare in 2023 Build a winning workforce strategy Learn how healthcare competition is transforming (www.advisory.com/healthcarecompetition)
Healthcare leaders are entering the new year with an unusually high number of short-term crises – things like rising costs, increased competition, and staffing shortages. So where should you be focusing your attention in 2023? In this episode host Rachel (Rae) Woods talks with executive strategy experts Natalie Trebes and Aaron Mauck about the complexities of today’s market and what should be on a leaders' radar for 2023. This episode is the first of a two-part series. Tune in next week when Rae brings Natalie and Aaron back to discuss what leaders can do today to shape the future of healthcare beyond 2023. Links: Ep. 142: The dire state of hospital finances (Part 1: Hospital of the Future series) Ep. 143: A new path for a sustainable financial future (Part 2: Hospital of the Future series) The outlook for healthcare in 2023 Build a winning workforce strategy Learn how healthcare competition is transforming (www.advisory.com/healthcarecompetition)
Every day it seems like there is a new challenge in the healthcare industry that requires immediate attention, making agenda and goal setting for the new year an even more difficult task. To help you decipher the signal from the noise host Rachel (Rae) Woods hands the microphone over to Advisory Board experts who will share the big questions on their radar in 2023 and the hypotheses that they plan to test. Topics include: (1:43) Shaping the new era of value-based care (5:50) Addressing the behavioral health crisis (8:54) Balancing care innovation and accessibility (13:38) Investing in the technology-enabled workforce (16:48) Competing on women's health (20:04) Forecasting the impact of industry diversification Links: The state of healthcare heading into 2023 Healthcare in 2022: An industry under pressure Ep. 124: The decisions shaping the future of healthcare PS: This is the final episode of 2022. A BIG thank you to all our guests who came on Radio Advisory this year to share their knowledge and insights and to the team behind the scenes who make this all happen. We made this special video to show our appreciation. New episodes will drop on January 10th, until then, have a happy and healthy new year. As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
In Part 1 of Radio Advisory's Hospital of the Future series, host Rachel (Rae) Woods invited experts to discuss cost-cutting strategies for hospitals facing financial hardships. But what if there are no more costs to cut? In Part 2 of the series, Rae invites Optum Executive Vice President Dr. Jim Bonnette to discuss the sustainability of modern-day hospitals and why scaling down might be the best strategy for a stable future. Links: Ep. 142: The dire state of hospital finances (Part 1: Hospital of the Future series) Our Strategy playlist Our Financial Impact playlist As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
The majority of hospitals are predicted to have negative margins in 2022, marking the worst year financially for hospitals since the beginning of the COVID-19 pandemic. In Part 1 of Radio Advisory's Hospital of the Future series, host Rachel (Rae) Woods invites Advisory Board experts Monica Westhead, Colin Gelbaugh, and Aaron Mauck to discuss why factors like workforce shortages, post-acute financial instability, and growing competition are contributing to this troubling financial landscape and how hospitals are tackling these problems. Links: 'The most difficult year': Why hospital finances are so strained Our Financial Impact playlist As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
Healthcare typically lags behind other industries when it comes to digital transformation. However, growing competition in the field means a solid digital consumer experience is becoming more crucial for organizations. In this episode, Rachel (Rae) Woods invites digital health experts Jordan Angers and Ty Aderhold to discuss what healthcare leaders need to consider when revamping their digital consumer strategy and how to ensure that patients who could benefit most from digital health aren’t being left behind. You will also want to stay tuned after their conversation because Rae has analysis of the midterm elections and what the results could mean for healthcare. Links: Is digital disruption helping patients—or only consumers? Ep. 21: Digital health and disruption in the Covid-19 era 2022 midterms: These healthcare initiatives passed on state ballots As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
In this episode, Radio Advisory is LIVE at Advisory Board’s 2022 Service Line Summit in St. Louis. Host Rachel Woods invites Advisory Board expert Fanta Cherif, Optum Rx senior director of pipeline and drug surveillance Bill Dreitlein, and Pear Therapeutics chief medical officer and head of development Dr. Yuri Marcich to have a gamified conversation about disruptive clinical products and how organizations can prepare for and embrace next-generation diagnostics and therapeutics. Links: Q&A: Why a disruptive therapy is more consequential than an innovative one Disruptive therapeutics and diagnostics cheat sheets 3 disruptive behavioral health therapeutics—and what they mean for health equity As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
More and more health plans are shifting away from their traditional “risk aggregator” roles and ushering in a new era of payer-provider relationships. In this episode, Rachel (Rae) Woods invites health plan, workforce and value-based care experts Mallory Kirby, Eliza Dailey, and Katie Everts to explain payvider relationships, why they’re becoming more common, and how to determine if becoming a payvider partnership is feasible for your organization. Links: Ep. 127: How health insurers are reinventing themselves Understanding the evolving health plan identity How health plan identity is evolving As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
Equity is top of mind for health leaders—but revelations about bias in artificial intelligence is giving increasing cause for concern. In this episode host Rachel (Rae) Woods invites Microsoft’s Director for Artificial Intelligence Tom Lawry to discuss how bias creeps into AI. Together, they discuss the ethical principles leaders can adopt to ensure AI is used responsibly, and what we can all do to make intelligent systems more equitable. Tom Lawry is the author of Hacking Healthcare, which details lessons learned from AI’s role during global pandemic and how to apply this knowledge to healthcare's other big challenges – including inequity. Links: [Tom's book] Hacking Healthcare: How AI and the Intelligence Revolution Will Reboot an Ailing System AI in healthcare What does the future of AI in cancer care look like? Here are 3 global start-ups that we're watching to decide. Prep for a new era of AI and analytics: 5 insights from Advisory Board's 2022 AI and analytics survey Ep. 103: What an equitable organization looks like and how yours can get there Our Technology playlist Our Health Equity and Racism playlist As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
More and more employees are rejecting hustle culture and embracing a workplace attitude called “quiet quitting” in which they meet the minimum requirements of their job. In this episode, Rachel (Rae Woods) talks with Joe Folkman, co-founder and President of the leadership and organizational development firm Zenger Folkman, about why he thinks quiet quitting is more of a reflection on leadership and not employees. Rae also talks with Advisory Board researchers Rachel Zuckerman and Allyson Paiewonsky about what quiet quitting could look like in clinical and non-clinical settings. Links: Are your workers 'quiet quitting'? Are your staff 'quiet quitting?' You need to build a better relationship with them. 'Quiet quitting' is happening in healthcare too As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
For decades Alzheimer's research was centered around one theory, the amyloid-beta hypothesis. That theory is now being called into question after evidence of potential fraud. In this episode, Rachel (Rae) woods invites life sciences expert Nick Hula and senior care expert Miriam Sznycer-Taub to talk about what this means for the scientific and medical community, how to restore trust in medical research, and where the industry may look to next when it comes to memory care. Links: Is a key Alzheimer's theory based on manipulated research? Ep. 90: Aaron Carroll on how clinicians can combat medical misinformation As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.
One of the biggest challenges healthcare leaders are grappling with is the workforce shortage, particularly in nursing. This isn’t a new problem, so why haven't we found real solutions? Host Rachel (Rae) Woods invites Henry Ford Health System's Vice President and Chief Innovation Officer Lisa Prasad and Senior Vice President and Chief Nursing Officer Eric Wallis to discuss why we need to look at the nursing shortage as a supply chain issue and what can be done both in short-term and long-term. Links: US workforce could be short 2.1 million nurses by 2025 Why 67% of nurses want to quit—and what would make them stay Our Clinical Workforce playlist Get the Daily Briefing newsletter in your inbox. Subscribe now.
Celebrity entrepreneur Mark Cuban wants to make buying drugs less complicated and more affordable, and an online pharmacy he recently invested in aims to do just that. So how does this work, and is it enough to solve the drug pricing problem in America? Host Rachel (Rae) Woods talks with pharmacy experts Gina Lohr and Chloe Bakst about this business model and drug pricing reforms in the recently passed Inflation Reduction Act. Links: Can Mark Cuban lower Medicare drug costs? A deeper dive into the headlines Could cost plus drug pricing save Medicare billions? Ep. 131: Healthcare disruptors: Why Walgreens wants to partner—not compete Get the Daily Briefing newsletter in your inbox. Subscribe now.
Radio Advisory is rounding out its healthcare disruptor series with an episode about possibly the biggest disruptor of all – Amazon. Their acquisition of One Medical is among the biggest investments in care delivery by a non-healthcare entity. The acquisition has kicked off an arms race for physicians, with organizations like CVS announcing their own massive deals. In this episode, Rachel (Rae) Woods invites digital health experts John League and Ty Aderhold to discuss why Amazon’s investments – and failures – are a catalyst for the rest of the industry (and where they are going next). Links: Amazon is buying One Medical for $3.9B. Here's our take. Who wins: Exploring Amazon’s One Medical acquisition and what it means today (Part 1) 3 scenarios: Exploring Amazon’s One Medical acquisition and what it means for the future of healthcare (Part 2) Amazon Care is shutting down. What's next?
(New/bonus content starts at 22:09. First part of episode originally aired November 2, 2021.) There's been plenty of talk about companies being disruptive in the healthcare industry, from Amazon to Walmart, but a company you might not be thinking about is also making moves into the healthcare world—Best Buy. In this episode, host Rachel Woods sits down with Advisory Board's Miriam Sznycer-Taub to talk about how Best Buy is moving its way into the healthcare world and what that might mean for the healthcare industry. Bonus links: Ep. 131: Healthcare disruptors: Why Walgreens wants to partner—not compete Ep. 130: Healthcare disruptors: Don't discount retailers FDA's new final rule opens up hearing aids to millions of Americans Links: Why you shouldn't rush into home-based care (and what to consider before entering) Home-based care market scan
This episode was recorded on August 5, 2022. In part two of Radio Advisory’s disruptor series, Rachel (Rae) Woods invites Walgreens Health Chief Clinical Officer Dr. Sashi Moodley to discuss the obstacles of being a disruptor in a crowded competitive field, building longitudinal relationships with patients instead of transactional, and Walgreens’s goal of becoming an equal player in the value-based care industry. Links: Ep. 130: Healthcare disruptors: Don't discount retailers Is 'Big Retail' the next big healthcare disruptor? Innovative players in care delivery competition: convenient care 3 reasons why pharmacy support is critical in an 'everywhere care' world Why the boom in digital pharmacies represents a crossroads for retail pharmacy
It seems like we’re always hearing about new disruptors and competitors aiming to shake up the way healthcare is designed, delivered, and paid for. Perhaps the most notable are the retail disruptors, like Walgreens Health or CVS Health. But how do you know if something is a potential threat that could have a real impact on your business? In this episode, Rachel (Rae) Woods invites healthcare strategy and planning experts Colin Gelbaugh and Gina Lohr to discuss retail disruptors and growing competition in the healthcare industry, and what leaders should be looking for in the future. Links: Is 'Big Retail' the next big healthcare disruptor? Innovative players in care delivery competition: convenient care 3 reasons why pharmacy support is critical in an 'everywhere care' world Why the boom in digital pharmacies represents a crossroads for retail pharmacy
Buzzwords and phrases like “equity”, “digital divide”, and “cultural competency” are used often health care. However, there’s no real consensus on their actual definitions, and that can be problematic. In this episode, host Rachel (Rae) Woods talks with value-based care expert Daniel Kuzmanovich and health equity researcher Darby Sullivan to discuss why language has never been more important in the industry, and how to ensure that your vocabulary aligns with your organization’s intentions. Links: Is the language we use hurting our equity efforts? It's hard to move VBC forward when nobody understands what you mean Why we hate the phrase 'win-win partnership' in value-based care
During the peak of the pandemic an estimated 9.4 million cancer screenings were missed – which we know led to delayed cancer diagnoses. In this episode, Rachel (Rae) Woods invites oncology experts Ashley Riley and Lauren Woodrow to discuss both the human and system-wide impacts of delayed cancer screenings and what health leaders can do to rebound. Links: Early data shows a rise in advanced cancer diagnoses. But it may not tell the whole story. Cancer market trends for 2022
Comments 
Download from Google Play
Download from App Store